Evolent Health Cash Per Share vs. Return On Equity

9EH Stock  EUR 10.80  0.10  0.93%   
Considering the key profitability indicators obtained from Evolent Health's historical financial statements, Evolent Health may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Evolent Health's ability to earn profits and add value for shareholders.
For Evolent Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Evolent Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Evolent Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Evolent Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Evolent Health over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Evolent Health Return On Equity vs. Cash Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Evolent Health's current stock value. Our valuation model uses many indicators to compare Evolent Health value to that of its competitors to determine the firm's financial worth.
Evolent Health is number one stock in cash per share category among its peers. It also is number one stock in return on equity category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolent Health's earnings, one of the primary drivers of an investment's value.

Evolent Return On Equity vs. Cash Per Share

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Evolent Health

Cash Per Share

 = 

Total Cash

Average Shares

 = 
2.11 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Evolent Health

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.0241
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Evolent Return On Equity Comparison

Evolent Health is currently under evaluation in return on equity category among its peers.

Evolent Health Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Evolent Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Evolent Health will eventually generate negative long term returns. The profitability progress is the general direction of Evolent Health's change in net profit over the period of time. It can combine multiple indicators of Evolent Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3800 people.

Evolent Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Evolent Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Evolent Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Evolent Health's important profitability drivers and their relationship over time.

Use Evolent Health in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolent Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolent Health will appreciate offsetting losses from the drop in the long position's value.

Evolent Health Pair Trading

Evolent Health Pair Trading Analysis

The ability to find closely correlated positions to Evolent Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolent Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolent Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolent Health to buy it.
The correlation of Evolent Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolent Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolent Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolent Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Evolent Health position

In addition to having Evolent Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Printing and Publishing Thematic Idea Now

Printing and Publishing
Printing and Publishing Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
View All  Next Launch

Additional Information and Resources on Investing in Evolent Stock

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
Check out Trending Equities.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
To fully project Evolent Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Evolent Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Evolent Health's income statement, its balance sheet, and the statement of cash flows.
Potential Evolent Health investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Evolent Health investors may work on each financial statement separately, they are all related. The changes in Evolent Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evolent Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.